Veru Inc. (VERU) compared with its closest peers (HYPD, TENX, GRCE, FLNA, MCRB). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Hyperion DeFi, Inc. (HYPD) | $47.90M | 14.6 |
| Tenax Therapeutics, Inc. (TENX) | $46.42M | -9.1 |
| Grace Therapeutics, Inc. (GRCE) | $46.28M | -9.9 |
| FILANA THERAPEUTICS, INC. (FLNA) | $46.27M | — |
| Seres Therapeutics, Inc. (MCRB) | $45.43M | 23.2 |
| Karyopharm Therapeutics Inc. (KPTI) | $44.57M | -0.4 |
| Silo Pharma, Inc. (SILO) | $43.59M | — |
| PDS Biotechnology Corporation (PDSB) | $40.23M | — |
| CervoMed Inc. (CRVO) | $39.61M | -2.6 |
| Apollomics, Inc. (APLM) | $37.46M | -0.2 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
VERU overview · VERU earnings · VERU financials · VERU KPIs · VERU investor relations · VERU ownership · VERU filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.